-
models. Current treatment strategies for HBV are life-long and rarely curative. Finite antiviral and immunomodulatory therapeutic strategies are being pursued for an HBV functional cure to treat the 254
-
This 2-year, full-time postdoc, starting January 2027 (or as soon as possible thereafter), is part of a French National Research Agency (ANR) funded project, UniGEM (Unified Inference for Genomic
-
across a range of clinically relevant pathogens. Develop novel computational methods to infer biological function directly from protein sequences, including modeling epistatic interactions and residue
-
. The project builds on our previous work on the dissemination of peptidoglycan fragments across the body from the gut. We are looking for somebody that has highly transversal expertise in biochemistry
-
PRDX6-PLA2 block intraerythrocytic blood stage growth. This collaborative project with Université de Lille and Institut Pasteur de Lille will develop and use high throughput assays to identify novel
-
, methodological rigor. Title of the project: Genetics of brain diversity in autism Laboratory: Human Genetics and Cognitive Functions Unit (dir. Thomas Bourgeron) Duration of the contract: 2 years Aim
-
fundamental mechanisms of host specialization, but will also provide a comprehensive effort to elucidate the exceptional virulence of Icterohaemorrhagiae strains. Your Role: You’ll work closely with other
-
://research.pasteur.fr/fr/department/immunology/ ). The Guermonprez lab investigates the role of dendritic cell subsets in regulating T cell responses and explores novel immunotherapeutic approaches (https
-
Position: Our laboratory is recruiting a postdoctoral fellow to investigate how senescent cells shape tissue function in vivo, particularly its interplay with cellular plasticity/reprogramming
-
Title of the project: Genetics of brain diversity in autism The laboratory: Human Genetics and Cognitive Functions Unit (Dir. Thomas Bourgeron) Duration of the contract: 2 years The aim